Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schrödinger, Inc. (“Schrödinger” or “the Company”) (NASDAQ: SDGR). Investors who purchased Schrödinger securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Schrödinger has violated federal securities laws.

Investigation Details

On May 20, 2025, Schrödinger issued a press release “announc[ing] that the company and Geoffrey Porges, MBBS., have mutually agreed that Dr. Porges will depart from his role as chief financial officer to pursue other opportunities.” On this news, Schrödinger’s stock price fell $2.03 per share, or 8.62%, to close at $21.53 on May 20, 2025.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Schrödinger securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660